Literature DB >> 34694799

Targeted Quantitative Profiling of GTP-Binding Proteins Associated with Metastasis of Melanoma Cells.

Rong Cai1,2, David Bade3, Xiaochuan Liu1, Ming Huang3, Tianyu F Qi3, Yinsheng Wang1,3.   

Abstract

Metastasis is a major obstacle in the therapeutic intervention of melanoma, and several GTP-binding proteins were found to play important roles in regulating cancer metastasis. To assess systematically the regulatory roles of these proteins in melanoma metastasis, we employed a targeted chemoproteomic method, which relies on the application of stable isotope-labeled desthiobiotin-GTP acyl phosphate probes in conjunction with scheduled multiple-reaction monitoring (MRM), for profiling quantitatively the GTP-binding proteins. Following probe labeling, tryptic digestion, and affinity pull-down of desthiobiotin-conjugated peptides, differences in expression levels of GTP-binding proteins in two matched pairs of primary/metastatic melanoma cell lines were measured using liquid chromatography-MRM analysis. We also showed that among the top upregulated proteins in metastatic melanoma cells, AK4 promotes the migration and invasion of melanoma cells; overexpression of AK4 in primary melanoma cells leads to augmented migration and invasion, and reciprocally, knockdown of AK4 in metastatic melanoma cells results in repressed invasiveness. In summary, we examined the relative expression levels of GTP-binding proteins in two pairs of primary/metastatic melanoma cell lines. Our results confirmed some previously reported regulators of melanoma metastasis and revealed a potential role of AK4 in promoting melanoma metastasis.

Entities:  

Keywords:  GTP-binding protein; cancer metastasis; chemoproteomics; melanoma; multiple-reaction monitoring; targeted proteomics

Mesh:

Substances:

Year:  2021        PMID: 34694799      PMCID: PMC8751237          DOI: 10.1021/acs.jproteome.1c00708

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  27 in total

1.  Skyline: an open source document editor for creating and analyzing targeted proteomics experiments.

Authors:  Brendan MacLean; Daniela M Tomazela; Nicholas Shulman; Matthew Chambers; Gregory L Finney; Barbara Frewen; Randall Kern; David L Tabb; Daniel C Liebler; Michael J MacCoss
Journal:  Bioinformatics       Date:  2010-02-09       Impact factor: 6.937

2.  Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion.

Authors:  Feng Xin; Dong-Wei Yao; Li Fan; Jiu-Hua Liu; Xiao-Dong Liu
Journal:  Clin Exp Med       Date:  2019-08-28       Impact factor: 3.984

3.  A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.

Authors:  Ming Huang; Tianyu F Qi; Lin Li; Gao Zhang; Yinsheng Wang
Journal:  Cancer Res       Date:  2018-08-02       Impact factor: 12.701

4.  Evidence of an intact N-terminal translocation sequence of human mitochondrial adenylate kinase 4.

Authors:  Christakis Panayiotou; Nicola Solaroli; Magnus Johansson; Anna Karlsson
Journal:  Int J Biochem Cell Biol       Date:  2009-09-18       Impact factor: 5.085

5.  Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.

Authors:  C Aubert; F Rougé; J R Galindo
Journal:  J Natl Cancer Inst       Date:  1980-05       Impact factor: 13.506

Review 6.  Transglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and death.

Authors:  H Tatsukawa; Y Furutani; K Hitomi; S Kojima
Journal:  Cell Death Dis       Date:  2016-06-02       Impact factor: 8.469

7.  Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1α to drive lung adenocarcinoma metastasis.

Authors:  Yi-Hua Jan; Tsung-Ching Lai; Chih-Jen Yang; Yuan-Feng Lin; Ming-Shyan Huang; Michael Hsiao
Journal:  J Hematol Oncol       Date:  2019-01-29       Impact factor: 17.388

8.  New Systematic Therapies and Trends in Cutaneous Melanoma Deaths Among US Whites, 1986-2016.

Authors:  Juliana Berk-Krauss; Jennifer A Stein; Jeffrey Weber; David Polsky; Alan C Geller
Journal:  Am J Public Health       Date:  2020-03-19       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.